NCT00438958 - Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other Diseases | Biotech Hunter

Enrollment

230

Participants

Timeline

Start Date

March 31, 2007

Conditions

Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemiaLymphomaMyelodysplastic SyndromesSecondary Myelofibrosis

Interventions

BIOLOGICAL

filgrastim

Given on day 0.

PROCEDURE

allogeneic bone marrow transplantation

Given on day 0

PROCEDURE

peripheral blood stem cell transplantation

Given on day 0

Trial Locations (16)

1

Auckland City Hospital, Auckland

3050

Royal Melbourne Hospital, Parkville

5000

Institute of Medical and Veterinary Science, Adelaide

11211

King Faisal Specialist Hospital and Research Center, Riyadh

98109-1024

Fred Hutchinson Cancer Research Center, Seattle

V5Z 4E3

Vancouver Hospital and Health Science Center, Vancouver

R3E 0V9

CancerCare Manitoba, Winnipeg

B3H 2Y9

Cancer Care Nova Scotia, Halifax

L8N 3Z5

McMaster Children's Hospital at Hamilton Health Sciences, Hamilton

N6A 465

London Regional Cancer Program at London Health Sciences Centre, London

K1H 8L6

Ottawa Hospital Regional Cancer Centre - General Campus, Ottawa

M5G 2M9

Princess Margaret Hospital, Toronto

H1T 2M4

Maisonneuve-Rosemont Hospital, Montreal

H3A 1A1

Royal Victoria Hospital - Montreal, Montreal

G1J 1Z4

Hopital de L'Enfant Jesus, Québec

G1R 2J6

Centre Hospitalier Universitaire de Quebec, Québec

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

The Canadian Blood and Marrow Transplant Group

NETWORK